Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication pursuant to Regulation 47 of SEBI (Listing O...more...
The company reported standalone net profit of Rs 0.21 crore for the quarter ended March 31 2026 as compared to Rs 0.20 crore in the same per...more...
Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Audited Financial Result for the Financial Year ended 31.03.2026more...
Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulatio...more...
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ...more...
ÿKETAN SHAHÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqu...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Intimation under Regulation 30 of the SEBI (Listing Obligatio...more...
The Company hereby submit drafts intimation letter sent to holders of Physical shares of the company for updating PAN KYC Nomination and other detail...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Biofil C...more...
As of March 2026 46.79% is owned by Indian Promoters and 53.21% by Public. Top five Promoters holding highest number of shares of Biofil Chem.&Pharma...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Submission of Publication in Newspaper pursuant to SEBI circular ...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Intimation regarding SEBI Circular dated January 30 2026 Ease of Doing Inv...more...
Intimation regarding SEBI Circular dated January 30 2026-Ease of Doing Investment- Special Window for Transfer and Dematerilaisation of Phys...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quar...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tr...more...
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication pursuant to Regulation 47 of SEBI (...more...
Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Un-Audited Financial Results of the Company for the quarter and nine month ended on 31st December 2025more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026